Christina Andreou, Prof. PhD MD

Deputy Research Group Leader (University of Lübeck, Germany) and Head of Inpatient Services (SRO Langenthal, Switzerland)

Education
1997 Medical Degree, Aristotle University of Thessaloniki (Greece)
2005 Board Certification in Psychiatry and Psychotherapy, Thessaloniki (Greece)
2005 – 2006 Extramural Distance Learning Program, Beck Institute for Cognitive Therapy and Research, PA (USA)
2007 PhD, Aristotle University of Thessaloniki (Greece)
2014 Habilitation / Venia legendi, University of Hamburg (Germany)
2021 Extraordinary Professor, University of Lübeck (Germany)

Professional Experience
1999 – 2005 Specialty training in Psychiatry & Psychotherapy, Aristotle University Thessaloniki (Greece)
2006 – 2010 Psychiatrist, Hellenic Center for Psychiatric Healthcare and Research, Thessaloniki (Greece)
2010 – 2015 Specialist in Psychiatry, City Hospital Braunschweig (Germany) & Department of Psychiatry & Psychotherapy, University Medical Center Hamburg-Eppendorf (Germany)
2015 – 2019 Consultant Psychiatrist, Center for Early Detection and Gender Research & Center for Psychotic Disorders, University Psychiatric Clinics, University of Basel (Switzerland)
Since 2017 Head of Outpatient Clinic for Early Intervention and Psychotic Disorders, University of Basel (Switzerland)
2019 – 2021 Consultant Psychiatrist, Co-Head of Track for Psychotic Disorders and Early Intervention, Department of Psychiatry and Psychotherapy, University of Lübeck (Germany)

Christina Andreou’s conducts translational research in psychotic disorders with a special focus on prediction- and treatment-relevant neurobiological mechanisms of psychotic symptoms. Her investigations include delusion associated cognitive biases, resting-state EEG connectivity, innovative treatments for delusions; outcome prediction and implementation of new healthcare models in the clinical high risk state and early psychosis.

Keywords: neurobiological mechanisms, outcome prediction, early psychosis, clinical high risk state, cognitive biases, EEG

1. Hauke D, Roth V, Karvelis P, Adams RA, Moritz S, Borgwardt S, Diaconescu AO, Andreou C. (2022). Increased belief instability in psychotic disorders predict treatment response to metacognitive training. Schizophrenia Bulletin 2022, in press
2. Mackintosh AJ, de Bock R, […] Borgwardt S, Andreou C. (2021). Psychotic disorders, dopamin- ergic agents and EEG/MEG resting-state functional connectivity: a systematic review. Neuroscience & Biobehavioral Reviews; 120:354-471.
3. De Bock R, Mackintosh AJ, […], Andreou C. (2020). EEG microstates as biomarkers for psychosis in high-risk patients. Translational Psychiatry; 10(1):300.
4. Moritz S, Scheunemann J, Lüdtke T, Westermann S, Pfuhl G, Balzan RP, Andreou C. (2020). Prolonged rather than hasty decision-making in schizophrenia using the box tak. Must we rethink the jumping to conclusions account of paranoia? Schizophrenia Research 222: 202-208.
5. Andreou C., Steinmann S, […], Moritz S, Mulert C. (2018). The role of effective connectivity between the task-positive and task-negative network for evidence gathering [Evidence gathering and connectivity]. Neuroimage. Jun;173:49-56

Grants as PI
Promotion Santé Suisse/BAG Project PsyYoung (2020-2024: 1.997.556 CHF total; main applicant, project leader)
SNF SPARK Grant (2019-2021; 98.430 CHF; main applicant)
SNF Project Grant (2017-2020; 372.000 CHF; main applicant)
DFG Project Grant (2014-2016: 226.160 € total / 110.418 € own sum; main applicant)
DFG Project Grant (2012-2014; 96.397 €; main applicant)

Fellowships
Research fellowships within SFB 936 (2012-2014) and TRR 58 (2014)

Awards
NARSAD Young Investigator Award, Brain & Behavior Research Foundation (56.000$)